The mission of Thomson Instrument Company is to partner with our customers, provide technical expertise and deliver practical scientific innovations.
No named decision-maker yet.
No careers mailbox known
Our Mission:. To optimize clinical decision making and improve patient safety.
Thomas Wenchell · Executive Officer, Director · decision-maker
C. Satti · Director
Careers mailbox is known
May 26, 2023
Raised a round Venture round $14.2M · SEC Form D
1981
Founded
Panome Bio delivers advanced multi-omics services including Next-Generation Metabolomics, Discovery Proteomics, Transcriptomics, and Integrated Multi-Omics.
Tom Cohen · Executive Officer · decision-maker
Edward Weinstein · Executive Officer, Director · decision-maker
Rob Capone · Director
Alexander Herzick · Director
Careers mailbox is known
May 27
Partnership TD2 Oncology and Panome Bio Partner to Advance Translational Oncology Through Integrated Multi-Omics Capabilities · streetinsider.com
Feb 25
Launched Panome Bio Introduces MassID, a Major Advance in Untargeted Metabolomics Data Analysis for Biomarker Discovery and Drug Development · YahooFinance
Nov 14, 2024
Raised a round Venture round $6M · SEC Form D
2022
Founded
IconPCR with AutoNorm gives you normalized, sequencing-ready NGS libraries in one step, with real-time per-well control for 16S metagenomics, RNA-Seq, and WGS.
No named decision-maker yet.
No careers mailbox known
Mosaic Biosciences is an integrated biologic discovery CRO specializing in antibody discovery, protein engineering, function-first screening, and early developability assessment.
No named decision-maker yet.
No careers mailbox known
Aug 17
Launched Mosaic Biosciences Launches New Product to Accelerate Crop Residue Breakdown and Improve Spring Field Readiness · morningstar.com
Aug 5
Partnership Mosaic Biosciences and Uniquity Bio Announce Strategic Collaboration in Biologics Development · mosaicbio.com
Cell Microsystems develops innovative tools that allow researchers to image, sort, and isolate single cells and colonies for use in the fields of CRISPR gene editing, cancer research, stem cell biology, immunology and neurobiology.
Christopher Sims · Executive Officer, Director · decision-maker
Gary Pace · Executive Officer, Director · decision-maker
Brett Williams · Director
Deval Lashkari · Director
No careers mailbox known
Jul 15
Launched Cell Microsystems Launches Software Supporting 21 CFR Part 11 Compliance, Expanding CellRaft AIR to Regulated Workflows · enterprisenews.com
Aug 23, 2023
Acquisition Cell Microsystems Acquires Fluxion Biosciences to Broaden Cell Analysis Product and Services Portfolio · fox4kc.com
Aug 11, 2023
Raised a round Venture round $6.5M · SEC Form D
2021
Founded
EditCo provides CRISPR gene editing services, CRISPR products & genome engineering solutions for disease models, drug discovery and cell therapy research.
No named decision-maker yet.
Careers mailbox is known
2018
Founded
Expert home telepsychiatry services with licensed providers in Montana, Idaho, & Alaska. Most insurance accepted, no referral needed. Taking new patients.
No named decision-maker yet.
No careers mailbox known
Feb 16
Board appointment Frontier Psychiatry Appoints Healthcare Industry Veteran Terry Boch to Board of Directors · tennessean.com
Kytopen is accelerating access to the next generation of cell therapies through scalable genome engineering by solving manufacturing problems at discovery.
Bethany Grant · Executive Officer · decision-maker
Michael Chiu · Director, Executive Officer · decision-maker
Julio Vega · Executive Officer · decision-maker
Paulo Garcia · Executive Officer, Director · decision-maker
Careers mailbox is known
2025
Team shrank to 6 was 13 · US Form 5500 (plan participants)
Apr 28, 2025
Partnership Kytopen Teams Up With Aldevron To Enhance Workflow Solutions For Cell Therapy Developers · Nasdaq
Feb 6, 2025
Raised a round Venture round $7.1M · SEC Form D
2017
Founded
